http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-102083064-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C49-255 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-05 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C49-255 |
| filingDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2020-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2020-02-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-102083064-B1 |
| titleOfInvention | pentadienone-resveratrol derivative, a method for producing the same, and an anticancer drug containing the same |
| abstract | The present invention relates to a pentadienone-resveratrol derivative, a method for preparing the same, and an anticancer agent comprising the same. Since the compound represented by Formula 1 according to the present invention has excellent anticancer activity, it may be useful as an anticancer agent. |
| priorityDate | 2017-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 332.